Tardive dystonic symptoms associated with aripiprazole treatment.
Lim
Hyun-Kook
HK
Pae
Chi-Un
CU
Lee
Chul
C
Lee
Chang-Uk
CU
D000328:Adult; D014150:Antipsychotic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D000068180:Aripiprazole; D015897:Comorbidity; D004409:Dyskinesia, Drug-Induced / Q000209:etiology*; D004421:Dystonia / Q000139:chemically induced*; D006801:Humans; D008607:Intellectual Disability / Q000453:epidemiology; D008297:Male; D015835:Ocular Motility Disorders / Q000139:chemically induced; D010879:Piperazines / Q000009:adverse effects* / Q000627:therapeutic use; D015363:Quinolones / Q000009:adverse effects* / Q000627:therapeutic use; D012559:Schizophrenia / Q000188:drug therapy / Q000453:epidemiology
D014150:Antipsychotic Agents; D010879:Piperazines; D015363:Quinolones; D000068180:Aripiprazole